SpringerLink
Log in

Is Levetiracetam a Superior Anti-Seizure Medication in Pediatric Status Epilepticus?

  • Invited Commentary
  • Published:
Indian Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price includes VAT (Canada)

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Marson A, Burnside G, Appleton R, et al. The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial. Lancet. 2021;397:1363–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Marson A, Burnside G, Appleton R, et al. The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multi-centre, phase 4, randomised controlled trial. Lancet. 2021; 397:1375–86.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Di Vito L, Mazzoni S, Belotti LMB, et al. Impact of regulatory restrictions on the use of valproic acid in women of childbearing age: An Italian study. Epilepsia. 2023;64:910–8.

    Article  CAS  PubMed  Google Scholar 

  4. Lyttle MD, Gamble C, Messahel S, et al. Emergency treatment with levetiracetam or phenytoin in status epilepticus in children-the EcLiPSE study: study protocol for a randomised controlled trial. Trials. 2017;18:283–10.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Dalziel SR, Furyk J, Bonisch M, et al. A multicentre randomised controlled trial of levetiracetam versus phenytoin for convulsive status epilepticus in children (protocol): Convulsive Status Epilepticus Paediatric Trial (ConSEPT) - a PREDICT study. BMC Pediatr. 2017;17:152–9.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Chamberlain JM, Kapur J, Shinnar S, et al. Efficacy of levetira-cetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial. Lancet. 2020;395:1217–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Angurana SK, Suthar R. Efficacy and safety of levetiracetam vs. phenytoin as second line antiseizure medication for pediatric convulsive status epilepticus: a systematic review and meta-analysis of randomized controlled trials. J Trop Pediatr. 2021;67:fmab014.

    Article  Google Scholar 

  8. AlMulihi QA, AlMuhanna FA, AlMuhanna MA, AlSultan EA. Comparison of Safety and effectiveness between levetiracetam and phenytoin in the treatment of pediatric status epilepticus: a meta- analysis. CNS Neurol Disord Drug Targets. 2023;22:745–51.

    Article  CAS  PubMed  Google Scholar 

  9. McIntyre J, Robertson S, Norris E, et al. Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial. Lancet. 2005;366:205–10.

    Article  CAS  PubMed  Google Scholar 

  10. McTague A, Martland T, Appleton R. Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children. Cochrane Database Syst Rev. 2018: CD001905.

  11. Elshater AA, Sadek AA, Abdelkreem E. Levetiracetam and midazolam vs midazolam alone for first-line treatment of children with generalized convulsive status epilepticus (Lev-Mid Study): a randomized controlled trial. Indian Pediatr. 2023: S097475591600514. Epub ahead of print

  12. Woolfall K, Roper L, Humphreys A, et al. Enhancing practitioners’ confidence in recruitment and consent in the EcLiPSE trial: a mixed-method evaluation of site training - a Paediatric Emergency Research in the United Kingdom and Ireland (PERUKI) study. Trials. 2019;20:181–14.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

Funding: None

Author information

Authors and Affiliations

  1. Apollo Hospitals International Ltd, Ahmedabad, Gujarat, India

    Anand S. Iyer

Authors
  1. Anand S. Iyer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anand S. Iyer.

Ethics declarations

Competing interests: None stated.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Iyer, A.S. Is Levetiracetam a Superior Anti-Seizure Medication in Pediatric Status Epilepticus?. Indian Pediatr 60, 617–618 (2023). https://doi.org/10.1007/s13312-023-2954-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13312-023-2954-6

Search

Navigation